Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9179026 | 1.00 | TSHR (0.55) | TSHRALDH1A1DNM1 | |
| SCHEMBL9177171 | 1.00 | TSHR (0.55) | TSHRALDH1A1DNM1 | |
| SCHEMBL4622170 | 0.98 | TSHR (0.52) | TSHRALDH1A1DNM1 | |
| SCHEMBL11607766 | 0.93 | TSHR (0.54) | TSHRALDH1A1DNM1 | |
| SCHEMBL14915468 | 0.90 | TSHR (0.62) | TSHRALDH1A1 | |
| SCHEMBL6551771 | 0.90 | TSHR (0.62) | TSHRALDH1A1 | |
| SCHEMBL14916205 | 0.88 | TSHR (0.61) | TSHRALDH1A1 | |
| SCHEMBL17310252 | 0.86 | TSHR (0.65) | TSHRALDH1A1 | |
| SCHEMBL29101465 | 0.84 | TSHR (0.62) | TSHRALDH1A1DNM1 | |
| SCHEMBL9073837 | 0.81 | TSHR (0.39) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4086280-A | FROM M-CHLOROPERBENZOIC ACID AND AN ALKYL ALKENYL TIN COMPOUND TO FORM EPOXIDE, HYDROGEN CHLORIDE | THE PROCTER & GAMBLE COMPANY (US) | 1978-04-25 | — | — | US | claimed |
| US-4065480-A | Process for preparing substituted cyclopropycarbinyl compounds | THE PROCTER & GAMBLE COMPANY (US) | 1977-12-27 | — | — | US | claimed |
| US-3998889-A | REACTING AN UNSATURATED ORGANO-TIN COMPOUND WITH AN ORGANIC SULFUR HALIDE | THE PROCTER & GAMBLE COMPANY (US) | 1976-12-21 | — | — | US | claimed |
| JP-62256809-A | — | — | None | — | — | JP | disclosed |
| US-20130115520-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, AND ELECTROCHEMICAL ELEMENT UTILIZING SAME | UBE INDUSTRIES, LTD. (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20080132477-A1 | Macrocyclic Compounds Useful as Bace Inhibitors | NOVARTIS AG (CH) | 2008-06-05 | — | — | US | disclosed |
| EP-1851208-A1 | MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS | Novartis AG (CH) | 2007-11-07 | — | — | EP | disclosed |
| WO-2006074950-A1 | MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS | NOVARTIS AG (CH) | 2006-07-20 | — | — | WO | disclosed |
| US-5475151-A | Catalytic hydrogenation of cyclopropanecarboxaldehyde with Raney nickel or cobalt | EASTMAN CHEMICAL COMPANY | 1995-12-12 | — | — | US | disclosed |
| JP-S62256809-A | ETHYLENE/ALPHA-OLFEIN COPOLYMER AND ITS PRODUCTION | JAPAN SYNTHETIC RUBBER CO LTD | 1987-11-09 | — | — | JP | disclosed |
| US-4086280-A | FROM M-CHLOROPERBENZOIC ACID AND AN ALKYL ALKENYL TIN COMPOUND TO FORM EPOXIDE, HYDROGEN CHLORIDE | THE PROCTER & GAMBLE COMPANY (US) | 1978-04-25 | — | — | US | disclosed |
| US-4085273-A | REACTING TRIBUTYL(1-CARBOALKOXY-2,2-DIMETHYL-3-BUTEN-1-YL)TIN WITH ACETYL FLUOBORATE, REACTING PRODUCT WITH METHYL METAL COMPOUND, DEHYDRATING PRODUCT WITH IODINE CATALYSIS | THE PROCTER & GAMBLE COMPANY (US) | 1978-04-18 | — | — | US | disclosed |
| US-4065480-A | Process for preparing substituted cyclopropycarbinyl compounds | THE PROCTER & GAMBLE COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
| US-3998889-A | REACTING AN UNSATURATED ORGANO-TIN COMPOUND WITH AN ORGANIC SULFUR HALIDE | THE PROCTER & GAMBLE COMPANY (US) | 1976-12-21 | — | — | US | disclosed |
| US-3959324-A | PESTICIDE, ANTIINFLAMMATORY | THE PROCTER & GAMBLE COMPANY (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132477-A1 | Macrocyclic Compounds Useful as Bace Inhibitors | BACE1, BACE2, APP | TSHR 4686/4885ALDH1A1 2631/4885DNM1 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.